SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014840
Filing Date
2022-08-04
Accepted
2022-08-04 16:52:33
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q oncr-20220630.htm   iXBRL 10-Q 2310568
2 EX-10.2 oncr-ex10_2.htm EX-10.2 304701
3 EX-31.1 oncr-ex31_1.htm EX-31.1 18852
4 EX-31.2 oncr-ex31_2.htm EX-31.2 18197
5 EX-32.1 oncr-ex32_1.htm EX-32.1 11239
6 EX-32.2 oncr-ex32_2.htm EX-32.2 10753
  Complete submission text file 0000950170-22-014840.txt   8327925

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20220630_pre.xml EX-101.PRE 277910
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncr-20220630_cal.xml EX-101.CAL 45681
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20220630_lab.xml EX-101.LAB 382016
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20220630.xsd EX-101.SCH 42215
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncr-20220630_def.xml EX-101.DEF 131323
60 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20220630_htm.xml XML 1558423
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39575 | Film No.: 221137468
SIC: 2834 Pharmaceutical Preparations